Literature DB >> 15074082

Apoptosis in atheroclerosis: implications for plaque destabilization.

W Martinet1, M M Kockx.   

Abstract

An increasing body of evidence from both animal models and human specimens suggests that apoptosis or programmed cell death is a major event in the pathophysiology of atherosclerosis. Although the significance of apoptosis in atherosclerosis remains unclear, it has been proposed that apoptotic cell death contributes to plaque instability, rupture and thrombus formation. In this study, we have outlined some of our most recent results concerning initiation of apoptosis in atherosclerosis with a special focus on oxidative DNA and RNA damage. Furthermore, we provide a detailed picture of the pro- and anti-apoptotic genes/proteins that are involved during the initiation of cell death in atherosclerotic plaques by using a combination of established immunohistochemical stainings and recent molecular biology techniques. Our data suggest that smooth muscle cells and macrophages in atherosclerotic plaques express a different panel of apoptosis-related genes in response to proapoptotic stimuli. Although this may seem a promising starting-point for the development of anti-atherogenic drugs, it remains to be determined whether modulation of apoptosis can become a clinically important approach to influence plaque progression.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15074082

Source DB:  PubMed          Journal:  Verh K Acad Geneeskd Belg        ISSN: 0302-6469


  6 in total

1.  Ischemic heart disease associated with bortezomib treatment combined with dexamethasone in a patient with multiple myeloma.

Authors:  Hiroyuki Takamatsu; Takeshi Yamashita; Takeharu Kotani; Aiko Sawazaki; Hirokazu Okumura; Shinji Nakao
Journal:  Int J Hematol       Date:  2010-05-11       Impact factor: 2.490

2.  Berberine inhibits HIV protease inhibitor-induced inflammatory response by modulating ER stress signaling pathways in murine macrophages.

Authors:  Weibin Zha; Guang Liang; Jian Xiao; Elaine J Studer; Phillip B Hylemon; William M Pandak; Guangji Wang; Xiaokun Li; Huiping Zhou
Journal:  PLoS One       Date:  2010-02-09       Impact factor: 3.240

3.  Multiple myeloma and diabetes.

Authors:  Zeinab A Issa; Mira S Zantout; Sami T Azar
Journal:  ISRN Endocrinol       Date:  2011-11-17

Review 4.  Clinical challenges: myeloma and concomitant type 2 diabetes.

Authors:  Yasar Albushra Abdul Rahiem Ahmed; Awad Eltayeb
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2013

5.  Clinical challenges: Myeloma and concomitant type 2 diabetes.

Authors:  Mohamed Ahmed Ali; Yasar A Ahmed; Abubaker Ibrahim
Journal:  South Asian J Cancer       Date:  2013-10

6.  BReast CAncer susceptibility gene 2 deficiency exacerbates oxidized LDL-induced DNA damage and endothelial apoptosis.

Authors:  Shweta Singh; Hien Nguyen; David Michels; Hannah Bazinet; Pratiek N Matkar; Zongyi Liu; Lilian Esene; Mohamed Adam; Antoinette Bugyei-Twum; Elizabeth Mebrahtu; Jameela Joseph; Mehroz Ehsan; Hao H Chen; Mohammad Qadura; Krishna K Singh
Journal:  Physiol Rep       Date:  2020-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.